The Role of Xpert MTB/RIF Ultra in Diagnosing Pulmonary Tuberculosis in Children.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

2 citing papers in PubMed.

1. Diagnosis of paediatric TB using XpertThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2022
   Article
2. Paediatric tuberculosis - new advances to close persistent gaps.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
   Article

Corrections and comments

• Comment on
  Tuberculosis Diagnosis in Children Using Xpert Ultra on Different Respiratory Specimens.2019

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as